IDiyas

For the Inventor, By the Inventor

Westfield, NJ, United States of America

Ali Shafiee

USPTO Granted Patents = 13

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 242(Granted Patents)


Company Filing History:

goldMedal13 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1992-2008

Loading Chart...
13 patents (USPTO):Explore Patents
1. 7429674 - Process for preparing fluoroleucine alkyl esters (2008-09-30),
2. 6403347 - HIV integrase inhibitors (2002-06-11),
3. 6177008 - Dual compartment solid phase extraction cartridge (2001-01-23),
4. 6110716 - HIV integrase inhibitors (2000-08-29),
5. 5972994 - Microbial transformation products with antifungal properties (1999-10-26),
6. 5858738 - Ermophilane sesquiterpenoids as HIV intergrase inhibitors (1999-01-12),
7. 5622866 - Expression cassettes useful in construction of integrative and (1997-04-22),
8. 5612217 - Streptomyces sp. MA 7074 (ATCC 55605) used for microbial synthesis of (1997-03-18),
9. 5491077 - Microbial method (1996-02-13),
10. 5427933 - Reduction of phenylalkyl ketones to the corresponding (S)-hydroxy (1995-06-27),
11. 5352783 - Microbial transformation product having immunosuppressive activity (1994-10-04),
12. 5264355 - Methlating enzyme from streptomyces MA6858 (1993-11-23),
13. 5149701 - C-31 methylated FR-900520 cyclic hemiketal immunosuppressant agents (1992-09-22),

Title: Spotlight on Inventor Ali Shafiee: Pioneering Innovations in Westfield, NJ

Introduction:

Ali Shafiee, a prolific inventor based in Westfield, NJ, has made significant contributions to the field of pharmaceuticals with his groundbreaking inventions. With an impressive portfolio of 13 patents to his name, Shafiee continues to push the boundaries of pharmaceutical research and development.

Latest Patents:

Shafiee's latest patents include a revolutionary process for preparing fluoroleucine alkyl esters, showcasing his expertise in stereoselective synthesis. Additionally, his work on HIV integrase inhibitors, specifically chaetochromins, demonstrates his commitment to combating infectious diseases like HIV and AIDS through innovative pharmaceutical solutions.

Career Highlights:

Currently affiliated with Merck & Company, Inc., Shafiee has been instrumental in driving forward the company's research efforts in the pharmaceutical industry. His expertise and dedication have led to the successful development of novel drug compounds that have the potential to transform patient care and treatment outcomes.

Collaborations:

In his professional journey, Shafiee has collaborated closely with esteemed colleagues such as Shieh-Shung T. Chen and Deborah L. Zink. Together, they have synergized their expertise to tackle complex scientific challenges and bring cutting-edge inventions to fruition.

Conclusion:

Ali Shafiee's remarkable career as an inventor exemplifies a relentless pursuit of innovation and a commitment to improving global health outcomes. His pioneering work in pharmaceutical research serves as a testament to the impact of dedicated inventors in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…